<DOC>
	<DOCNO>NCT01852019</DOCNO>
	<brief_summary>To demonstrate patient treated cangrelor directly switch oral prasugrel patient treat prasugrel switch cangrelor without significant decrease extent inhibition platelet aggregation .</brief_summary>
	<brief_title>Cangrelor Prasugrel Transition Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Cangrelor</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>1. great / equal 18 less 75 year age 2. stable coronary artery disease define follow criterion 1 . Previous myocardial infarction define admission hospital elevation marker injury presence pathologic Q wave least 2 contiguous electrocardiogram ( ECG ) lead . OR 2 . Previous revascularization percutaneous coronary intervention ( PCI ) coronary artery bypass graft ( CABG ) . AND 3 . Treatment aspirin ( ASA ) 81 mg daily .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>CAD</keyword>
</DOC>